Statements of Cash Flows - USD ($)	12 Months Ended
Statements of Cash Flows - USD ($)	Jun. 30, 2025	Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (17,542,120)	$ (32,120,533)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of intangible assets	229,377	229,377
Stock based compensation - restricted stock units and restricted shares	1,202,809	1,763,450
Stock based compensation expense - stock options	1,195,447	2,823,764
Stock based compensation expense - issuance of common stock for services rendered	73,680	72,900
Amortization of financing costs	11,820	108,751
Accretion of unearned loan discount	111,212	1,023,145
Accretion of loan premium	25,758	236,970
Realized gain on maturity of available-for sale		(223,865)
Non-cash lease expense from right-of-use assets	67,073	49,346
Gain on termination of operating lease		(5,215)
Change in fair value of derivative liabilities	(3,771)	(1,816,271)
Changes in operating assets and liabilities:
Grant receivable	(2,104,050)
Prepaid and other current assets	(845,505)	(101,866)
Accounts payable and accrued expenses	(1,386,592)	110,653
Operating lease liabilities	(60,343)	(47,245)
Other current liabilities		(48,385)
Net cash used in operating activities	(19,025,205)	(27,945,024)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from U.S. Treasury Bills (available-for-sale)		14,525,000
Net cash provided by investing activities		14,525,000
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of common stock	15,674,613	27,802,939
Proceeds from exercise of warrants	2,901,341	(10,000,000)
Payment of loan premium	(850,000)
Payments of note payable	(5,000,000)
Net cash provided by financing activities	12,725,954	17,802,939
Net change in cash and cash equivalents	(6,299,251)	4,382,915
Cash and cash equivalents, beginning of period	23,843,798	19,460,883
Cash and cash equivalents, end of period	17,544,547	23,843,798
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	183,930	1,525,056
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Right of use assets obtained in exchange for lease obligations		432,192
Reclassification of unrealized gains on U.S. Treasury Bills (available-for-sale investments) upon settlement		176,591
Deemed dividend for ratchet adjustment to warrants	$ 369,465	$ 886,423

BIOVIE INC. 10-K